Physician profile
Anna Subramaniam
NPI 1184156150
$1,991.02
in general payments reported to CMS, 2019-2025
9 companies · $1,100 in 2025
The $1,100 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $891 · 2025: $1,100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,770 · Travel and Lodging: $213 · Education: $7.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.24 |
| Travel and Lodging | $212.83 |
| Education | $7.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asahi Intecc USA, INC. | $410.24 | 2025 | Asahi Coronary Wires, Asahi Peripheral Vascular Wires |
| Abbott Laboratories | $307.10 | 2024 | Diamondback Coronary, Xience Skypoint, Perclose Prostyle |
| Teleflex LLC | $305.55 | 2025 | Manta, Guideliner, Turnpike |
| Penumbra, INC. | $264.77 | 2024 | Indigo System |
| Boston Scientific Corporation | $249.06 | 2024 | |
| Medtronic, INC. | $201.33 | 2025 | Resolute Onyx |
| Abiomed | $146.91 | 2025 | |
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Angiodynamics, INC. | $35.77 | 2025 | Alphavac, Unifuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Subramaniam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.